This is a story of a highly specialized drug, Ilaris, which is sold by Novartis for $16,000 a dose or $64,000 a year. They sell to under 10,000 patients a year. Novartis discovered that the drug may also have a beneficial impact on heart attack survivors....
Author: Reed Holden
Okay, so managing a sales team can be tough. You have a sales team that is in the field doing all they can to hit their numbers and you’re at half-time. You’re asking, “Will we be where we need to be at the end of the year?” The question you should...
We are all used to the tough negotiators. Be they in procurement or some other part of the firm, these guys push, distort the truth, and apparently do anything to get a lower price – even if it puts their own business at risk.
It was a simple conversation with 40 pricing professionals, part of a “current events” topic in pricing session. Towards the end, one of the pricing directors for a line of machines raised her hand and said, “I’m about to have...
Sign Up for Insights
Holden Advisors is a team of experts in pricing and sales performance.
We help build and protect our clients’ pricing power by leveraging decades of expertise in negotiation, sales strategy, and value-based pricing.
